The activity of Nucleo CMP forte is due to the inclusion of its active components in certain metabolic pathways. Nucleo CMP forte contributes to the group of phosphates necessary for the metabolism of cerebrosides, as well as sphingomyelin and glycerophospholipids, phosphatidic acids, which make up the main components of the myelin sheath, which gives the product trophic properties for maturation and axonal regeneration of nervous tissue.
Nucleo CMP Forte is a nucleotide-based preparation consisting of cytidine monophosphate, uridine monophosphate, uridine diphosphate and uridine triphosphate. It is prescribed for diseases of the peripheral nervous system, such as lumboishialgia, diabetic or alcoholic polyneuropathy or trigeminal neuralgia.
Little attention has been paid to its effect on brain pathology. Nucleo CMP Forte studies show that the nucleotides included in Nucleo CMP Forte are promising therapeutic molecules to prevent the death of neurons in the brain caused by focal ischemia, Parkinson's disease or other neurodegenerative pathologies.
Made in Spain by Ferrer International.
Specifications
Experimental tests on animals with neuropathy have shown that the introduction of Nucleo CMP forte has a preventive and curative effect. After administration, an increase in the density of the damaged nerve fiber is confirmed, as well as its diameter, that is, an increase in its consistency and thickness. This is expressed in the activation of the axon regeneration mechanism and an increase in the speed of axonal flow. Consequently, inflammation decreases, sensitivity increases and mobility of the affected area improves.
Indications
Neuromuscular diseases due to a deficiency of any of the components of the product.
Neuralgia, neuritis, myalgia, nervous exhaustion and functional recovery.